// LIVE.FEED

Frontier signal stream

21 Jul 2026 00:00
💰 Funding & Capital Raises

Colossal Biosciences reported in talks to raise at a $20bn-$30bn valuation

Axios reported that Colossal was in discussions for a new funding round valuing the de-extinction company at $20bn to $30bn, against the $10.2bn it achieved in its $200m Series C and the $10.3bn carried after a $120m dodo-specific raise in September 2025. Total capital raised to date is roughly $555m; no round has been confirmed as closed.

Dallas Business Journal, reporting AxiosUNLISTED SOURCEC
22 Apr 2026 00:00
💰 Funding & Capital Raises

Revive & Restore awards $3.4m to ten projects in inaugural Climate Resilience Fund cohort

Revive & Restore announced the first cohort of its Climate Resilience Fund on Earth Day, awarding $3.4 million across ten projects that apply genetic rescue technologies to marine and coastal ecosystems threatened by climate change. The organisation received 160 Letters of Intent requesting approximately $52 million — more than fifteen times the available funds — of which 24 proposals advanced to full review before a ten-person external panel, and ten were selected. The portfolio covers mangroves (2), kelp forests (2), marine microbes (2), seagrass meadows (1), salt marshes (1), fucoid macroalgae (1) and sea turtles (1), spanning the US Atlantic and Pacific coasts, Southeast Asia, the Caribbean and Australia. Revive & Restore describes the fund as a strategic expansion into the climate space and deeper into genetic rescue for marine species including plants, algae and microbial life. Dr Liv Liberman, Director of Ocean and Climate and programme manager for the fund, said the projects are intended to demonstrate that genetic rescue is 'a powerful lever for the blue carbon ecosystems that underpin both ecological and human communities'. Co-founder and Executive Director Ryan Phelan stated the organisation plans to 'build on that momentum and bring the same approach to terrestrial ecosystems next'.

Revive & RestoreCOMPANYA